Cargando…
Does Pre-Treatment with High Dose Atorvastatin Prevent Microvascular Dysfunction after Percutaneous Coronary Intervention in Patients with Acute Coronary Syndrome?
BACKGROUND AND OBJECTIVES: There is controversy surrounding whether or not high dose statin administration before percutaneous coronary intervention (PCI) decreases peri-procedural microvascular injury. We performed a prospective randomized study to investigate the mechanisms and effects of pre-trea...
Autores principales: | Lee, Bong-Ki, Koo, Bon-Kwon, Nam, Chang-Wook, Doh, Joon-Hyung, Chung, Woo-Young, Cho, Byung-Ryul, Fearon, William F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Cardiology
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4965425/ https://www.ncbi.nlm.nih.gov/pubmed/27482255 http://dx.doi.org/10.4070/kcj.2016.46.4.472 |
Ejemplares similares
-
Effect of Atorvastatin on Serial Changes in Coronary Physiology and Plaque Parameters
por: Lee, Cheol Hyun, et al.
Publicado: (2022) -
Clinical Relevance of Ischemia with Nonobstructive Coronary Arteries According to Coronary Microvascular Dysfunction
por: Lee, Seung Hun, et al.
Publicado: (2022) -
Functional Approach for Coronary Artery Disease: Filling the Gap Between Evidence and Practice
por: Lee, Joo Myung, et al.
Publicado: (2018) -
Differential Prognostic Implications of Pre- and Post-Stent Fractional Flow Reserve in Patients Undergoing Percutaneous Coronary Intervention
por: Zhang, Jinlong, et al.
Publicado: (2021) -
High-dose atorvastatin pretreatment could diminishes microvascular impairment in patients undergoing elective percutaneous coronary intervention
por: He, Gui-Xin, et al.
Publicado: (2013)